Trial Endpoints for Candidemia and Invasive Candidiasis: Consensus Recommendations by the Mycoses Study Group Education & Research Consortium and European Confederation of Medical Mycology.
Invasive candidiasis (IC) remains the most common invasive mycosis world-wide, responsible for a wide range of infections that can range from superficial mucosal infections to life-threatening systemic diseases. Clinical trials of antifungal agents for IC are pivotal to its management. Therapeutic responses in these tr...